12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Benzinga16:06 ET

What's Going On With Moleculin Biotech Shares Wednesday?

Benzinga13:34 ET

Moleculin Biotech Shares Rise After Announcing Preclinical Data for Annamycin Targeting Venetoclax-Resistant Leukemia

MT Newswires13:33 ET

Express News | Moleculin Biotech Shares Are Trading Higher After the Company Announced the Online Publication of Preclinical Data for Its Annamycin Venetoclax Resistant AML Model Which Demonstrated Significant Activity

BenzingaDec 11 08:27 ET

New Findings Show Moleculin's Annamycin Overcomes Resistance to Venetoclax in AML

PR NewswireNov 18 08:15 ET

Express News | Moleculin Amends Clinical Trial Protocol With FDA For Its Phase 3 Trial Of Annamycin In Combination With Cytarabine; Amended Protocol Accelerates Unblinding Of Prelim. Primary Efficacy Data And Safety/Tolerability Of Three Arms At First 45 Subjects

BenzingaNov 14 08:20 ET